JP2026012402A5 - - Google Patents

Info

Publication number
JP2026012402A5
JP2026012402A5 JP2025185622A JP2025185622A JP2026012402A5 JP 2026012402 A5 JP2026012402 A5 JP 2026012402A5 JP 2025185622 A JP2025185622 A JP 2025185622A JP 2025185622 A JP2025185622 A JP 2025185622A JP 2026012402 A5 JP2026012402 A5 JP 2026012402A5
Authority
JP
Japan
Prior art keywords
lnp
nucleic acid
mol
tissue
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025185622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026012402A (ja
Filing date
Publication date
Priority claimed from PCT/US2020/056252 external-priority patent/WO2021077066A1/en
Application filed filed Critical
Publication of JP2026012402A publication Critical patent/JP2026012402A/ja
Publication of JP2026012402A5 publication Critical patent/JP2026012402A5/ja
Pending legal-status Critical Current

Links

JP2025185622A 2019-10-18 2025-11-04 薬物送達のための脂質及び脂質ナノ粒子製剤 Pending JP2026012402A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201962923258P 2019-10-18 2019-10-18
US62/923,258 2019-10-18
PCT/US2020/056252 WO2021077066A1 (en) 2019-10-18 2020-10-19 Lipid and lipid nanoparticle formulation for drug delivery
JP2022523031A JP2022552009A (ja) 2019-10-18 2020-10-19 薬物送達のための脂質及び脂質ナノ粒子製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2022523031A Division JP2022552009A (ja) 2019-10-18 2020-10-19 薬物送達のための脂質及び脂質ナノ粒子製剤

Publications (2)

Publication Number Publication Date
JP2026012402A JP2026012402A (ja) 2026-01-23
JP2026012402A5 true JP2026012402A5 (cg-RX-API-DMAC7.html) 2026-01-30

Family

ID=75538682

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022523031A Pending JP2022552009A (ja) 2019-10-18 2020-10-19 薬物送達のための脂質及び脂質ナノ粒子製剤
JP2025185622A Pending JP2026012402A (ja) 2019-10-18 2025-11-04 薬物送達のための脂質及び脂質ナノ粒子製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2022523031A Pending JP2022552009A (ja) 2019-10-18 2020-10-19 薬物送達のための脂質及び脂質ナノ粒子製剤

Country Status (8)

Country Link
US (1) US20220396556A1 (cg-RX-API-DMAC7.html)
EP (1) EP4045020A4 (cg-RX-API-DMAC7.html)
JP (2) JP2022552009A (cg-RX-API-DMAC7.html)
KR (1) KR20220084365A (cg-RX-API-DMAC7.html)
CN (1) CN114828836A (cg-RX-API-DMAC7.html)
AU (1) AU2020368556B2 (cg-RX-API-DMAC7.html)
CA (1) CA3155074A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021077066A1 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117098541A (zh) 2020-11-25 2023-11-21 阿卡格拉医药公司 用于递送核酸的脂质纳米粒及相关使用方法
CN113785975B (zh) * 2021-09-09 2023-08-29 天津医科大学 精胺、亚精胺脂质体在抗氧化、抗衰老中的应用
AR128959A1 (es) * 2022-04-04 2024-06-26 Spark Therapeutics Inc Mejora inmunológica del tratamiento del cáncer
WO2023196527A2 (en) * 2022-04-08 2023-10-12 SunVax mRNA Therapeutics Inc. Ionizable lipid compounds and lipid nanoparticle compositions
WO2023230587A2 (en) 2022-05-25 2023-11-30 Akagera Medicines, Inc. Lipid nanoparticles for delivery of nucleic acids and methods of use thereof
WO2024061354A1 (zh) * 2022-09-23 2024-03-28 北京键凯科技股份有限公司 一种抑制top1基因表达的干扰rna及其应用
CN118946544A (zh) * 2023-03-09 2024-11-12 上海吉量医药工程有限公司 可离子化脂质分子及其制备方法和应用
CN116082184B (zh) * 2023-04-12 2023-06-30 山东大学 基于环己二胺的可电离脂质、脂质纳米颗粒及其制备方法与应用
WO2025038494A1 (en) 2023-08-11 2025-02-20 Tune Therapeutics, Inc. Compositions, systems, and methods for lymphoid cell differentiation using targeted gene activation
EP4777496A1 (en) * 2023-09-11 2026-07-22 The Trustees of The University of Pennsylvania Compositions and methods for t cell targeted extrahepatic delivery of therapeutic agents
CN117482066B (zh) * 2023-11-02 2024-08-13 深圳市易瑞生物技术股份有限公司 脂质组合物和用于脂质组合物的化合物
WO2025209467A1 (en) * 2024-04-01 2025-10-09 Longuide Biopharma Corporation Lipids and lipid nanoparticle formulations
WO2026003582A2 (en) 2024-06-27 2026-01-02 Axelyf ehf. Lipids and lipid nanoparticles
WO2026161895A1 (en) 2025-01-27 2026-07-30 Tune Therapeutics, Inc. Compositions, systems, and methods for epigenetic regulation of lipoprotein a (lpa) gene expression

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009303345B2 (en) * 2008-10-09 2015-08-20 Arbutus Biopharma Corporation Improved amino lipids and methods for the delivery of nucleic acids
WO2010053572A2 (en) * 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US7635707B1 (en) * 2008-11-10 2009-12-22 Intermune, Inc. Pirfenidone treatment for patients with atypical liver function
WO2015011633A1 (en) * 2013-07-23 2015-01-29 Protiva Biotherapeutics, Inc. Compositions and methods for delivering messenger rna
WO2018081638A1 (en) * 2016-10-27 2018-05-03 The Trustees Of The University Of Pennsylvania Nucleoside-modified rna for inducing an adaptive immune response

Similar Documents

Publication Publication Date Title
JP2025175052A5 (cg-RX-API-DMAC7.html)
JP2022552008A5 (cg-RX-API-DMAC7.html)
JP2022552009A5 (cg-RX-API-DMAC7.html)
JP4842821B2 (ja) ポリエチレングリコール修飾脂質化合物およびその使用
JP2021535227A5 (cg-RX-API-DMAC7.html)
JP4951338B2 (ja) 脂質に封入された干渉rna
US20200016274A1 (en) Messenger rna vaccines and uses thereof
CN103476431B (zh) 包含阳离子脂质的用于带负电荷的药物的载体及其制备方法
US20180245074A1 (en) Treating hepatitis b virus infection using crispr
US9730893B2 (en) Lipid assemblies comprising anionic lysolipids and use thereof
JP2001502299A (ja) リポソーム
US12485170B2 (en) Lipid composition targeting antigen-presenting cells and use thereof
JP2001527052A5 (cg-RX-API-DMAC7.html)
JP2024529343A5 (cg-RX-API-DMAC7.html)
CN1981044A (zh) 包封干扰rna的脂质
JP2025541727A (ja) 新規のポリグリセロールコンジュゲート脂質及びそれを含む脂質ナノ粒子組成物
JP2000143549A (ja) ポリヌクレオチドを細胞にトランスフェクトさせる治療用組成物の製造におけるマグネシウム(Ma2+)の使用、および遺伝子治療に有用な組成物
AU2023211981A1 (en) Poly(alkyloxazoline)-lipid conjugates and lipid particles containing same
RU2476204C2 (ru) Носитель лекарственного средства
JP2005513073A6 (ja) ポリヌクレオチドを細胞へトランスフェクションするための組成物の製造のためのリゾ脂質の使用
JP2025505258A (ja) 疾患の治療方法および/または予防方法に使用するための製剤
US20230190653A1 (en) Method for reducing off-target uptake or accumulation of agents
CA3249260A1 (en) MODIFIED TRANSFER RNA WITH ENHANCED ACTIVITY
WO2026020403A1 (en) Ionizable lipid derived from alkyl substituted 1, 4, 7-triazacyclononane or 1, 4, 7, 10-tetraazacyclododecane, compositions and uses thereof
JP2002533354A (ja) 安定なポジプレックスの懸濁液の製造法